ECCMID 2021: ATOMIC2 Study Results
touchINFECTIOUSDISEASES were pleased to meet with Timothy Hinks (Nuffield Department of Medicine, University of Oxford, Oxford, UK) to discuss the results of the ATOMIC2 study results, investigating azithromycin in the treatment of COVID-19.
COVID-19 in clinical practice
Dr Tiwaskar and Dr Kinra share their experiences of managing patients at the onset of the COVID-19 pandemic and the key lessons learnt in clinical practice within India and the UK.
HIVR4P 2021: T Cell Responses of SARS-CoV-2 Epitopes
We were delighted to have the opportunity to speak with Dr Alba Grifoni ( La Jolla Institute for Immunology, La Jolla, CA, USA) to discuss T Cell responses of SARS-CoV-2 epitopes in COVID-19 cases.
ISNTD d3 2021: Ivermectin for COVID-19
It was a delight to be able to speak with Dr Carlos Chaccour (University of Barcelona, Barcelona, Spain) about the controversy currently surrounding the use of ivermectin for the treatment of COVID-19.
EASL ILC 2021: Tenofovir in Hepatitis B Patients with COVID-19
It was lovely to speak with Dr Beatriz Mateos (Universidad de Alcalá, Madrid, Spain) about the findings from her research into the impact of tenofovir on the severity of COVID-19 infection in those with chronic hepatitis B.
Mucormycosis: What is it and how can it be avoided in patients with COVID-19
Prof. Partha Kar, Dr Syed Shoeb Ahmad and Dr Neil Stone share their insights into the risk factors for mucormycosis in patients with COVID-19 and how it can be avoided.
COVID-19: How can transmission be prevented and controlled?
Join Dr Sanjay Kalra as he discusses viral transmission in COVID-19 and strategies to prevent transmission.
CME activities are developed by touchIME for touchINFECTIOUS DISEASES.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!